U. Davies

Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin.

A. Charlett, M. Preece, J. Reeve, 1997, Arthritis and rheumatism.

Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.

P. Woo, M. Preece, J. Reeve, 2000, The Journal of rheumatology.

Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone.

P. Woo, M. Preece, B. Ansell, 1994, The Journal of rheumatology.

hPTH 1–34 treatment of osteoporosis with added hormone replacement therapy: Biochemical, kinetic and histological responses

P. Meunier, J. Reeve, J. Green, 1991, Osteoporosis International.

Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.

J. Reeve, R. Hesp, D. Katz, 1990, BMJ.